Integra Lifesciences Holdings Corp (NASDAQ:IART) reaffirmed FY22 revenue guidance at the midpoint of its August 2022 guidance of $1.551 billion – $1.563 billion with an estimate of $1.57 billion. It raised FY22 adj EPS outlook to $3.29 – $3.33 versus an estimate of $3.24.
Titanium Miner LB Group Seeks to Shine in Hong Kong IPO Raising up to $1.5 Billion
Key Takeaways:
LB Group has filed for a Hong Kong IPO to raise up to $1.5 billion, aiming to consolidate its place as Asia’s leading producer of titanium dioxide pigments
Listing would complement company’s existing Shenzhen A-shares, which look sharply undervalued compared with industry peers
By Andrew Curran
